Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children
General Track – Cycle 1 | DrugsHTA Council Recommendation (as of 14 May 2025)
The HTA Council does not recommend the government financing of ceftaroline fosamil for the treatment of community-acquired pneumonia (CAP) in the pediatric population. (See below for more details)
Relevant Information
- Status: With HTA Council Final Recommendation
- Topic Assignment: External Assessment
- Policy Question: Should ceftaroline fosamil for the treatment of community-acquired pneumonia (CAP) in the pediatric population be funded by the government
- Secretary of Health Decision: Pending
Evidence and Relevant Documents
- HTA Council Preliminary Recommendation
- HTA Council Final Recommendation
- Secretary of Health Decision – pending publication
- Evidence Summary